comparemela.com
Home
Live Updates
Msi High - Breaking News
Pages:
2
3
4
5
6
7
8
Latest Breaking News On - Msi high - Page 1 : comparemela.com
Data Surrounding Treatment for MSI-high Patients from ASCO 2024
Dr Kim offers key perspective for MSI-high patients based on data presented at ASCO 2024.
Expert perspectives
Evolving treatment
Refractory metastatic colorectal cancer
Surrounding treatment
Colorectal cancer
Mcrc treatment
Colorectal cancer treatment
Msi high
High microsatellite instability
Asco 2024
Clinical trial data
Dostarlimab Plus Chemo Granted EU Approval for dMMR/MSI-H Endometrial Cancer
The European Commission has granted marketing authorization to dostarlimab paired with carboplatin and paclitaxel in adults with dMMR/MSI-H primary advanced or recurrent endometrial cancer who are eligible to receive systemic treatment.
European commission
European union
European commission
Dostarlimab plus carboplatin and paclitaxel
Endometrial cancer
Msi high
Systemic Therapy for Prostate Cancer
A urologic oncology fellow provides a comprehensive overview of systemic therapy options for patients with prostate cancer.
Prostate cancer treatment landscape
Prostate cancer
Systemic therapy
Prostate cancer treatments
Msi high
Pd 1 inhibitors
Pd l1 inhibitors
Lnrh agonists
Hormone therapy
Gnrh antagonists
Radium 223
Impact of Microsatellite Stability in Metastatic Colorectal Cancer
Dr Marshall describes the impacts of microsatellite stability and instability on metastatic colorectal cancer.
Johnl marshall
Pathology report
Microsatellite stable
Microsatellite instability
Next gen sequencing
Fragment analysis
Genetic analysis
Germline testing
Msi high
Metastatic disease
Rontline immunotherapy
Germline mutation
Lynch syndrome
Role of Biomarkers in Advanced Ovarian Cancer
Experts on advanced ovarian cancer give detailed insights on the role of biomarker testing and identify important biomarkers.
Advanced ovarian cancer treatment
Recent updates
Later line maintenance settings
Advanced ovarian
Advanced ovarian cancer
Epithelial ovarian cancer
Germline mutations
Biomarker testing
Tumor testing
Parp inhibitors
Ca 125
Genomic instability score
Loss of heterozygosity
Msi high
Homologous recombination deficiency
vimarsana © 2020. All Rights Reserved.